+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Oncology NGS Market by Product Type (Platforms, Reagents and Consumables, Services), Cancer Type (Breast Cancer, Colorectal Cancer, Hematological Malignancies), Application, End User - Global Forecast 2025-2030- Product Image
Oncology NGS Market by Product Type (Platforms, Reagents and Consumables, Services), Cancer Type (Breast Cancer, Colorectal Cancer, Hematological Malignancies), Application, End User - Global Forecast 2025-2030- Product Image
Sale

Oncology NGS Market by Product Type (Platforms, Reagents and Consumables, Services), Cancer Type (Breast Cancer, Colorectal Cancer, Hematological Malignancies), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715540
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Oncology next generation sequencing (NGS) continues to reshape cancer diagnostics and personalized care, enabling decision-makers to drive clinical impact, operational efficiency, and strategic value across their organizations. As market growth accelerates, precise, action-ready intelligence on evolving technologies, supply dynamics, and competitive moves is essential to inform forward-looking strategies.

Market Snapshot: Oncology NGS Market Size & Growth

The Oncology NGS Market grew from USD 504.37 million in 2024 to USD 583.57 million in 2025. It is expected to continue expanding at a robust CAGR of 15.57%, reaching USD 1.20 billion by 2030. This sustained growth reflects rapid adoption of sequencing-based oncology diagnostics, improved workflow efficiencies, and increased investment across diagnostic laboratories, research institutions, and industry consortia. The market demonstrates increasing global relevance, with new applications and user groups accelerating demand for actionable genomic insights in oncology.

Scope & Segmentation of the Global Oncology Next Generation Sequencing Market

Coverage spans the breadth of the Oncology NGS Market, illuminating technology adoption, key regional developments, and stakeholder priorities. This report examines multiple segmentation angles fundamental to stakeholder decision-making:

  • Product Type: Includes platforms such as benchtop and high throughput sequencers; reagents and consumables including flow cells, library prep kits, and sequencing kits; and a comprehensive suite of services like data analysis and sample preparation.
  • Cancer Type: Segmentation addresses major clinical needs, including breast cancer, colorectal cancer, hematological malignancies, and lung cancer, as each demands targeted assay design and workflow integration.
  • Application: Encompasses gene panels, RNA sequencing, and whole exome sequencing, each advancing diagnostic resolution and personalized therapy options.
  • End User: Framework defines academic research institutes, diagnostic laboratories, hospitals, and pharma/biotech companies as distinct drivers of demand and innovation.
  • Region: Detailed analysis spans the Americas, Europe, Middle East & Africa, and Asia-Pacific, with focused reviews of leading national markets including the United States, China, Germany, and Japan.
  • Company Coverage: Assessment of market dynamics and trends among leading players such as Illumina, Thermo Fisher Scientific, Roche, BGI Genomics, QIAGEN, and others essential to the competitive landscape.

Key Takeaways for Decision-Makers

  • Shifts toward high-throughput automation and cloud-based bioinformatics platforms are simplifying complex multi-omics analyses for clinical adoption and research scalability.
  • Rapid advances in sequencing chemistry and sample preparation continue to reduce turnaround times and expand clinical utility, supporting precision oncology and targeted therapy deployment.
  • Integration of AI-driven analytics accelerates biomarker discovery and data interpretation, making real-time, actionable outcomes possible for more patient cohorts.
  • Industry collaborations increasingly emphasize co-developed, integrated solutions—blending hardware, reagents, and analytics to reduce validation bottlenecks and streamline adoption.
  • Regional strategies are critical; as population genomics initiatives expand, local manufacturing and distribution partnerships help navigate regulatory and supply-chain complexity.

Tariff Impact on Oncology Sequencing Technologies

Recent U.S. tariff implementations on sequencing instruments and consumables have added complexity to procurement and distribution, impacting budgets and installation schedules. Stakeholders are adapting by exploring reagent rental agreements, co-development arrangements, and supply-chain optimization to maintain accessibility and operational continuity. Increased collaboration between regional biotech firms and global suppliers is facilitating compliance and supporting uninterrupted access to advanced oncology sequencing solutions.

Methodology & Data Sources

This analysis is grounded in primary interviews with leading oncologists, pathologists, laboratory directors, and industry executives, supplemented by rigorous secondary research from peer-reviewed literature, regulatory filings, conference materials, and corporate disclosures. Triangulation and expert validation methodologies were applied to ensure reliability and precision in both qualitative and quantitative trends.

Why This Report Matters to Executives

  • Enables leaders to pinpoint technology investments and partnership opportunities that align with strategic revenue growth and competitive positioning.
  • Provides actionable insight into supply-chain resilience, regulatory navigation, and service portfolio optimization amid a rapidly changing trade and technology landscape.

Conclusion & Forward View

This report equips stakeholders with the clarity to anticipate market shifts, optimize operational decision-making, and advance organizational objectives in oncology next generation sequencing. Strategic alignment across innovation, partnerships, and regional markets remains essential for sustained advantage in this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of liquid biopsy NGS assays for early detection and monitoring of treatment response in diverse cancer types
5.2. Adoption of comprehensive tumor profiling panels combining genomic and transcriptomic analysis for personalized oncology decisions
5.3. Emergence of AI-driven bioinformatics platforms to streamline interpretation of complex cancer NGS datasets across research and clinical labs
5.4. Expansion of decentralized NGS testing through portable sequencers enabling point-of-care oncology diagnostics in resource-limited settings
5.5. Growth of companion diagnostic development using NGS to identify actionable mutations for targeted therapy eligibility
5.6. Increasing collaboration between pharmaceutical companies and sequencing service providers to accelerate biomarker-driven drug development
5.7. Advancements in multiomics NGS approaches integrating epigenetic and proteomic data for deeper understanding of tumor heterogeneity
5.8. Rising focus on regulatory harmonization for NGS-based oncology tests to ensure global market access and standardization
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Oncology NGS Market, by Product Type
8.1. Introduction
8.2. Platforms
8.2.1. Benchtop Sequencers
8.2.2. High Throughput Sequencers
8.3. Reagents And Consumables
8.3.1. Flow Cells
8.3.2. Library Prep Kits
8.3.3. Sequencing Kits
8.4. Services
8.4.1. Data Analysis Services
8.4.2. Sample Preparation Services
9. Oncology NGS Market, by Cancer Type
9.1. Introduction
9.2. Breast Cancer
9.3. Colorectal Cancer
9.4. Hematological Malignancies
9.5. Lung Cancer
10. Oncology NGS Market, by Application
10.1. Introduction
10.2. Gene Panels
10.3. Rna Sequencing
10.4. Whole Exome Sequencing
11. Oncology NGS Market, by End User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Diagnostic Laboratories
11.4. Hospitals
11.5. Pharma And Biotech Companies
12. Americas Oncology NGS Market
12.1. Introduction
12.2. Mexico
12.3. Argentina
12.4. United States
12.5. Canada
12.6. Brazil
13. Europe, Middle East & Africa Oncology NGS Market
13.1. Introduction
13.2. Sweden
13.3. Egypt
13.4. Qatar
13.5. Saudi Arabia
13.6. Denmark
13.7. France
13.8. Switzerland
13.9. Poland
13.10. United Arab Emirates
13.11. Netherlands
13.12. South Africa
13.13. Israel
13.14. Finland
13.15. Italy
13.16. Nigeria
13.17. Russia
13.18. United Kingdom
13.19. Turkey
13.20. Norway
13.21. Spain
13.22. Germany
14. Asia-Pacific Oncology NGS Market
14.1. Introduction
14.2. China
14.3. South Korea
14.4. Philippines
14.5. India
14.6. Malaysia
14.7. Thailand
14.8. Taiwan
14.9. Vietnam
14.10. Indonesia
14.11. Japan
14.12. Australia
14.13. Singapore
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Illumina, Inc.
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Roche Holding AG
15.3.4. BGI Genomics Co., Ltd.
15.3.5. QIAGEN N.V.
15.3.6. Agilent Technologies, Inc.
15.3.7. PerkinElmer, Inc.
15.3.8. Eurofins Scientific SE
15.3.9. Guardant Health, Inc.
15.3.10. Sophia Genetics SA
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ONCOLOGY NGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ONCOLOGY NGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ONCOLOGY NGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ONCOLOGY NGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ONCOLOGY NGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ONCOLOGY NGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ONCOLOGY NGS MARKET: RESEARCHAI
FIGURE 24. ONCOLOGY NGS MARKET: RESEARCHSTATISTICS
FIGURE 25. ONCOLOGY NGS MARKET: RESEARCHCONTACTS
FIGURE 26. ONCOLOGY NGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ONCOLOGY NGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ONCOLOGY NGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ONCOLOGY NGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BENCHTOP SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BENCHTOP SEQUENCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HIGH THROUGHPUT SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HIGH THROUGHPUT SEQUENCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ONCOLOGY NGS MARKET SIZE, BY FLOW CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ONCOLOGY NGS MARKET SIZE, BY FLOW CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LIBRARY PREP KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LIBRARY PREP KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SEQUENCING KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SEQUENCING KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ONCOLOGY NGS MARKET SIZE, BY DATA ANALYSIS SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ONCOLOGY NGS MARKET SIZE, BY DATA ANALYSIS SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SAMPLE PREPARATION SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SAMPLE PREPARATION SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ONCOLOGY NGS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ONCOLOGY NGS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ONCOLOGY NGS MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ONCOLOGY NGS MARKET SIZE, BY GENE PANELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ONCOLOGY NGS MARKET SIZE, BY GENE PANELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ONCOLOGY NGS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ONCOLOGY NGS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ONCOLOGY NGS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ONCOLOGY NGS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ONCOLOGY NGS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ONCOLOGY NGS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ONCOLOGY NGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PHARMA AND BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ONCOLOGY NGS MARKET SIZE, BY PHARMA AND BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 81. MEXICO ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 82. MEXICO ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 83. MEXICO ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 84. MEXICO ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 85. MEXICO ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 86. MEXICO ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 87. MEXICO ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 88. MEXICO ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 89. MEXICO ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 90. MEXICO ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 91. MEXICO ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. MEXICO ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. MEXICO ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. MEXICO ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 98. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 99. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 100. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ONCOLOGY NGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 125. CANADA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. CANADA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. CANADA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 128. CANADA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 129. CANADA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 130. CANADA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 131. CANADA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 132. CANADA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 133. CANADA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 134. CANADA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 135. CANADA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. CANADA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. CANADA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. CANADA ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA ONCOLOGY NGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 169. SWEDEN ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. SWEDEN ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. SWEDEN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 172. SWEDEN ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 173. SWEDEN ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 174. SWEDEN ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 175. SWEDEN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 176. SWEDEN ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 177. SWEDEN ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 178. SWEDEN ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 179. SWEDEN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. SWEDEN ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. SWEDEN ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. SWEDEN ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. EGYPT ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. EGYPT ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. EGYPT ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 186. EGYPT ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 187. EGYPT ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 188. EGYPT ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 189. EGYPT ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 190. EGYPT ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 191. EGYPT ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 192. EGYPT ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 193. EGYPT ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. EGYPT ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. EGYPT ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. EGYPT ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. QATAR ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 198. QATAR ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 199. QATAR ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 200. QATAR ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 201. QATAR ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 202. QATAR ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 203. QATAR ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 204. QATAR ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 205. QATAR ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 206. QATAR ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 207. QATAR ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. QATAR ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. QATAR ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. QATAR ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 214. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 216. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 218. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 220. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. SAUDI ARABIA ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. DENMARK ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. DENMARK ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. DENMARK ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 228. DENMARK ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 229. DENMARK ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 230. DENMARK ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 231. DENMARK ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 232. DENMARK ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 233. DENMARK ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 234. DENMARK ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 235. DENMARK ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. DENMARK ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. DENMARK ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. DENMARK ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. FRANCE ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. FRANCE ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. FRANCE ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 242. FRANCE ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 243. FRANCE ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 244. FRANCE ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 245. FRANCE ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 246. FRANCE ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 247. FRANCE ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 248. FRANCE ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 249. FRANCE ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. FRANCE ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. FRANCE ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. FRANCE ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 256. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 257. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 258. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 259. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 260. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 261. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 262. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 263. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. SWITZERLAND ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. POLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 268. POLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 269. POLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 270. POLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 271. POLAND ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 272. POLAND ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 273. POLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 274. POLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 275. POLAND ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 276. POLAND ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 277. POLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. POLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. POLAND ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. POLAND ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 298. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 299. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 300. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 301. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 302. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. ISRAEL ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 324. ISRAEL ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 325. ISRAEL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 326. ISRAEL ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 327. ISRAEL ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 328. ISRAEL ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 329. ISRAEL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 330. ISRAEL ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 331. ISRAEL ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 332. ISRAEL ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 333. ISRAEL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 334. ISRAEL ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 335. ISRAEL ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. ISRAEL ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. FINLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 338. FINLAND ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 339. FINLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 340. FINLAND ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 341. FINLAND ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 342. FINLAND ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 343. FINLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 344. FINLAND ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 345. FINLAND ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 346. FINLAND ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 347. FINLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 348. FINLAND ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 349. FINLAND ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 350. FINLAND ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 351. ITALY ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 352. ITALY ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 353. ITALY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 354. ITALY ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 355. ITALY ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 356. ITALY ONCOLOGY NGS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 357. ITALY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 358. ITALY ONCOLOGY NGS MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 359. ITALY ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 360. ITALY ONCOLOGY NGS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 361. ITALY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 362. ITALY ONCOLOGY NGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 363. ITALY ONCOLOGY NGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 364. ITALY ONCOLOGY NGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 365. NIGERIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 366. NIGERIA ONCOLOGY NGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 367. NIGERIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2018-2024 (USD MILLION)
TABLE 368. NIGERIA ONCOLOGY NGS MARKET SIZE, BY PLATFORMS, 2025-2030 (USD MILLION)
TABLE 369. NIGERIA ONCOLOGY NGS MARKET SIZE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Oncology NGS market report include:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Roche Holding AG
  • BGI Genomics Co., Ltd.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • PerkinElmer, Inc.
  • Eurofins Scientific SE
  • Guardant Health, Inc.
  • Sophia Genetics SA

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 583.57 Million
Forecasted Market Value ( USD ) by 2030 $ 1200 Million
Compound Annual Growth Rate15.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

NGS Sample Preparation Market by Product Type (Amplification Kits, Fragmentation and Size Selection, Library Prep Kits), Application (Epigenetics, Metagenomics, Rna Sequencing), Technology, Workflow Step, End User - Global Forecast 2025-2030 - Product Image

NGS Sample Preparation Market by Product Type (Amplification Kits, Fragmentation and Size Selection, Library Prep Kits), Application (Epigenetics, Metagenomics, Rna Sequencing), Technology, Workflow Step, End User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
NGS Library Preparation Automation Market by Product Type (Consumables, Instruments, Software), Application (Epigenetics Analysis, Metagenomics, Targeted Sequencing), Automation, End User - Global Forecast 2025-2030 - Product Image

NGS Library Preparation Automation Market by Product Type (Consumables, Instruments, Software), Application (Epigenetics Analysis, Metagenomics, Targeted Sequencing), Automation, End User - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Analysis Report By Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis), By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Analysis Report By Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis), By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 125 Pages
  • Global
From
NGS Oncology Global Market Report 2025 - Product Image

NGS Oncology Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Oncology NGS Market: Analysis By Technology, By Workflow, By Application, By End User, By Region Size and Trends - Forecast up to 2029 - Product Image

Oncology NGS Market: Analysis By Technology, By Workflow, By Application, By End User, By Region Size and Trends - Forecast up to 2029

  • Report
  • 152 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.